International Symposium on CathepsinC

In Honor of Prof. Niels Borregaard

5 April -6 April, 2017
TOURS / FRANCE

Hôtel Oceania L'Univers Tours

The International Symposium ISyCatC will focus on the targeting of  cathepsin C, a protease that activates most of tissue-degrading proteases during inflammatory diseases such as COPD, cystic fibrosis, bronchiectasis, granulomatosis with polyangiitis or rheumatoid arthritis. Cathepsin C thus appears as a potential therapeutic target to impair protease-driven  tissue  degradation  in  chronic inflammatory diseases.

This symposium will bring together for the first time the world leading specialists from academic labs and industry,  working  on  cathepsin  C  and  its  target enzymes.   It will associate biochemists studying the functionality of cathepsin C, cell biologists studying its maturation and tissue localization, chemists developing specific cathepsin C  inhibitors and clinicians studying the pathologies in  which cathepsin C is directly or indirectly involved.

Chair: Brice Korkmaz

Phone: +33 2 47 36 63 86
E-mail: brice.korkmaz@inserm.fr

Scientific committee:
Francis Gauthier, Gilles Lalmanach, Adam Lesner (Poland)
Sylvain Marchand-Adam, Sandrine Dallet-Choisy